On August 13, POET Technologies (NASDAQ:POET) reported second-quarter revenue of $569,925, up 112% from a year earlier and its sixth straight quarter of sequential growth. Net loss narrowed to $11.3 million, or $0.07 a share, from $12.3 million in the first quarter. The company, which designs photonic integrated circuits for the AI and data center markets, now holds $796.3 million in cash, a war chest that dwarfs its current revenue base. That gap between balance sheet and business is the story here.
Six Straight Quarters Of Momentum
POET’s growth streak is getting harder to wave off as a fluke. Revenue climbed 13% from the first quarter and more than doubled from a year ago, the sixth straight quarter of sequential gains. That momentum came with real business behind it. During the quarter, POET signed a supply agreement with Lumilens that opened with a $50 million purchase order for Optical Interposer-based engines, and management said the wider relationship could eventually total more than $500 million in purchases stretched across five years.
After the quarter closed, an existing customer placed a new $2.4 million order, and POET reached an agreement with a top-tier laser maker for a new external light source engine. It also locked in an exclusive supplier arrangement meant to boost the output power of its Blazar hybrid laser. None of that would matter much without money to build it, and POET has plenty. The company closed a $400 million financing in May that priced above where the stock was trading, and ended the quarter holding $796.3 million in cash and short-term investments. That cushion let the board bring in Dr. Sandeep Kumar as chief operating officer to run the manufacturing ramp management expects to hit full stride in the back half of 2026.
Growth Still Comes At A Cost
Zoom out and the absolute numbers look different. Even after doubling, quarterly revenue landed at $569,925, a rounding error next to the $796.3 million sitting in the bank. Turning an interposer design business into a real manufacturer is consuming a lot more cash than it brings in. Cash used in operations widened to $12.2 million in the quarter, from $8.8 million in the first quarter and $7.8 million a year earlier, and research and development spending climbed to $5.8 million from $3.1 million a year ago as the company shifts from developing the technology itself to developing actual products. Stock-based compensation was $3.8 million, up from $1.2 million a year earlier.
The cash pile itself came with a price. The $400 million raise added 19,047,620 new units to the share count, each paired with a warrant exercisable at $26.25 through May 2029, more dilution the company will eventually have to absorb. Investors did not exactly cheer the results either, sending the shares down 6.54% the day they came out. And on the corporate structure front, the board decided against redomiciling to the US for now, leaving an open question some shareholders had hoped would resolve differently.
Skeptics Still Outnumber The Believers
Hedge fund ownership rose to 23 funds in the most recent quarter from 14 before, a real jump in institutional interest. Short sellers have not backed off, though, with 12.86% of the float sold short, a heavy position this early in a commercial ramp. That combination is a genuine split. Some investors are buying the growth story; others are betting the cash burn wins out.
The Long Road Still Ahead
POET’s story right now is a race between a fast-growing order book and an even faster-growing cash burn. The Lumilens relationship and the new customer commitments give bulls a real path to a business that eventually matches its balance sheet. But that path only works if the production ramp promised for the second half of the year actually ships on schedule and at the volumes management is hinting at. Bears would point out that the widening operating cash outflow shows the cost of getting there is rising too. Whether 2026 finally closes that gap is the question the next few quarters have to answer.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
